Kopp Family Office, LLC - VIRIDIAN THERAPEUTICS INC ownership

Quarter-by-quarter ownership
Kopp Family Office, LLC ownership history of VIRIDIAN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$3,287
-35.5%
214,2900.0%2.08%
-24.0%
Q2 2023$5,098
+52.6%
214,290
+63.2%
2.74%
+52.1%
Q1 2023$3,340
+77.6%
131,288
+103.9%
1.80%
+59.0%
Q4 2022$1,88164,3881.13%
Other shareholders
VIRIDIAN THERAPEUTICS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 680,768$11,376,0002.18%
COMMODORE CAPITAL LP 185,781$3,104,0001.24%
Ghost Tree Capital, LLC 300,000$5,013,0001.18%
Logos Global Management LP 550,000$9,191,0000.90%
Atlas Venture Advisors, Inc. 209,505$3,501,0000.65%
BVF INC/IL 463,504$7,745,0000.29%
SILVERARC CAPITAL MANAGEMENT, LLC 27,586$461,0000.25%
Fairmount Funds Management LLC 35,092$581,0000.24%
Soleus Capital Management, L.P. 67,685$1,131,0000.20%
Cormorant Asset Management, LP 459,144$7,672,0000.17%
View complete list of VIRIDIAN THERAPEUTICS INC shareholders